Exhibit 99.1

ExamWorks Reports Second Quarter 2014 Financial Results;

Record Revenues of $196.4 million; Record Adjusted EBITDA of $34.6 million;

Raises Full Year 2014 Guidance;

Announces National Account Wins

ATLANTA, GA. July 29, 2014– ExamWorks Group, Inc. (NYSE: EXAM), a leading provider of independent medical examinations, peer reviews, bill reviews, Medicare compliance, case management, and other related services (“IME services”), today reported financial results for the second quarter of 2014.

Second Quarter 2014 Highlights

Commentary

Commenting on today's earnings announcement, James K. Price, Chief Executive Officer of ExamWorks, said: “Once again we are proud of the efforts of our employees around the world.  We are also very excited that as a result of our Gould & Lamb and MedAllocators acquisitions during the first half of this year we are now the leading provider of Medicare compliance services for workers’ compensation and liability claims in the country. By growing into these new areas we continue to further partner with our clients to help them manage costs and enhance their risk and compliance management processes with services and capabilities that are unparalleled in the IME industry.”

Richard E. Perlman, Executive Chairman of ExamWorks, said: “Our results are a validation of every aspect of our global strategy.  We are extremely excited about the continuing momentum of our business as we continue to take advantage of market opportunities.  Our revised guidance for the year speaks of our confidence in the future. ”

Financial Review

Revenues – For the three months ended June 30, 2014, revenues were $196.4 million, an increase of 25.8% over the $156.1 million of revenues generated in the second quarter of 2013. The increase in revenues was primarily due to organic growth of 16.0% and, to a lesser extent, acquisition growth of 9.8%.

For the six months ended June 30, 2014, revenues were $369.5 million, an increase of 21.2% over the $304.9 million of revenues generated in the comparable period in 2013. The increase in revenues was primarily due to organic growth of 12.7% and, to a lesser extent, acquisition growth of 8.5%.

On a pro forma basis, for the three months ended June 30, 2014, pro forma revenues were $203.3 million, an increase of 13.7% over the $178.8 million in pro forma revenues in the second quarter of 2013. On a constant currency basis, our pro forma growth was 12.4% and was driven by growth across all of our geographies.

On a pro forma basis, for the six months ended June 30, 2014, pro forma revenues were $389.5 million, an increase of 11.8% over the $348.4 million in pro forma revenues in the comparable period in 2013. On a constant currency basis, our pro forma growth was 11.5% and was driven by growth across all of our geographies.

Below is a table presenting our revenues and growth rates for each of the regions we serve and, separately, pro forma revenues and growth rates for acquisitions completed from December 2013 to June 2014 (collectively, the “Recent Acquisitions”). The numbers presented below are pro forma for the effect of acquisitions completed in 2013 and 2014.

(a) The constant FX columns represent growth rates excluding the effects of currency.

Costs of revenues – For the three months ended June 30, 2014, costs of revenues were $124.9 million, an increase of 22.3% over the $102.1 million in costs of revenues in the second quarter of 2013. The increase was primarily due to increased revenues. Costs of revenues as a percentage of revenues for the second quarter of 2014 were 63.6% compared to 65.4% in the prior year quarter and the result of positive operating leverage from acquisitions and organic revenue growth. Included in costs of revenues in the second quarter of 2013 and 2014 are approximately $719,000 and $492,000 of share-based compensation expenses, respectively.

Selling, general and administrative expenses (“SGA”) – For the three months ended June 30, 2014, SGA expenses were $42.6 million, an increase of 25.0% over the $34.1 million in SGA expenses in the second quarter of 2013. The increase was primarily due to acquired SGA and higher share-based compensation expenses and transaction costs and other expenses in the second quarter of 2014 when compared to the prior year quarter. Included in SGA expenses in the second quarter of 2014 are $4.1 million in share-based compensation expenses and $948,000 in acquisition-related transaction costs and other expenses. Included in SGA expenses in the second quarter of 2013 are $3.6 million in share-based compensation expenses and $769,000 in acquisition-related transaction costs and other expenses.

Depreciation and amortization expenses (“D&A”) – For the three months ended June 30, 2014, D&A expenses were $14.9 million, a decrease of 5.7% over the $15.8 million in D&A expenses in the second quarter of 2013. The decrease was primarily due to intangible assets becoming fully amortized in 2013. For the three months ended June 30, 2014, depreciation expense was $1.6 million and amortization expense was $13.3 million.

Interest and other expenses, net – For the three months ended June 30, 2014, interest and other expenses, net were $8.1 million, a slight increase over the $7.7 million in interest and other expenses, net in the second quarter of 2013.

Adjusted EBITDA – For the three months ended June 30, 2014, adjusted EBITDA was $34.6 million, an increase of 38.4% over the $25.0 million in adjusted EBITDA in the second quarter of 2013.

For the six months ended June 30, 2014, adjusted EBITDA was $62.6 million, an increase of 30.4% over the $48.0 million in adjusted EBITDA in the comparable period in 2013.

Adjusted EBITDA is a non-GAAP measure that is described and reconciled to net income (loss) below and is not a substitute for the GAAP equivalent.

Other financial data – We generated $18.8 million of cash flow from operations in the first six months of 2014, after the $11.25 million bond interest payments made in January 2014. We ended the quarter with $7.9 million of cash on hand, $477.4 million of total debt and total leverage as calculated under our credit facility of approximately 3.75x. As of the end of the quarter, our committed availability under our credit facilities was approximately $90 million, all of which was immediately available.

Business Outlook

ExamWorks is providing the following business outlook for the third quarter and full year of 2014:

About ExamWorks Group

ExamWorks Group, Inc. is a leading provider of independent medical examinations, peer reviews, bill reviews, Medicare compliance, case management, and related services (“IME services”). We help our clients manage costs and enhance their risk management processes by verifying the validity, nature, cause and extent of claims, identifying fraud and providing fast, efficient and quality IME services. ExamWorks is focused on providing clients a national presence while maintaining the local service and capabilities they need and expect.

Non-GAAP Financial Measures

In connection with the ongoing operation of our business, our management regularly reviews Adjusted EBITDA, a non-GAAP financial measure, to assess our performance. We define Adjusted EBITDA as earnings before interest, taxes, depreciation, amortization, acquisition-related transaction costs, share-based compensation expenses, and other expenses. We believe that Adjusted EBITDA is an important measure of our operating performance because it allows management, lenders, investors and analysts to evaluate and assess our core operating results from period to period after removing the impact of changes to our capitalization structure, acquisition-related costs, income tax status, and other items of a non-operational nature that affect comparability.

We believe that various forms of the Adjusted EBITDA metric are often used by analysts, investors and other interested parties to evaluate companies such as ours for the reasons discussed above. Additionally, Adjusted EBITDA is used to measure certain financial covenants in our credit facility. Adjusted EBITDA is also used for planning purposes and in presentations to our Board of Directors as well as in our incentive compensation programs for our employees.

Non-GAAP information should not be construed as an alternative to GAAP information, as the items excluded from the non-GAAP measures often have a material impact on our financial results. Management uses, and investors should use, non-GAAP measures in conjunction with our GAAP results.

Below is a table presenting a reconciliation to Adjusted EBITDA from net income (loss), the most comparable GAAP measure, for each of the periods indicated.

Forward Looking Statements

Statements made in this press release that express ExamWorks' or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements, which ExamWorks intends to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. These statements often include words such as "may," "will," "should," "believe," "expect," "anticipate," "intend," "plan," "estimate," or the negative of these terms or other similar expressions that convey uncertainty of future events or outcomes. Forward-looking statements may include information concerning ExamWorks' possible or assumed future results of operations, including descriptions of ExamWorks' revenues, profitability, outlook and overall business strategy. You should not place undue reliance on these statements because they are subject to numerous uncertainties and factors relating to ExamWorks' operations and business environment, all of which are difficult to predict and many of which are beyond ExamWorks' control. Although ExamWorks believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many uncertainties and factors could affect ExamWorks' actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements, including but not limited to: our ability to implement our growth strategy and acquisition program; our ability to integrate completed acquisitions; our expansion into international markets; our increasing reliance on national account clients; our ability to secure additional financing; regulation of our industry; our information technology systems and the risk of security and data breaches; our ability to protect our intellectual property rights and other information; our ability to compete successfully with our competitors; our ability to monitor and retain qualified physicians and other medical providers; our ability to obtain, retain and grow customer relationships; our ability to provide accurate health-related risk assessment analyses of data; our ability to comply with existing and future regulation; our ability to retain key management personnel; and restrictions in our credit facility, senior notes indenture and future indebtedness. In addition, the risks discussed in our periodic reports, registration statements and other filings with the Securities and Exchange Commission could cause actual results to differ materially from the results anticipated by forward-looking statements.

You should keep in mind that any forward-looking statement made by ExamWorks herein, or elsewhere, speaks only as of the date on which made. ExamWorks expressly disclaims any intent, obligation or undertaking to update or revise any forward-looking statements made herein to reflect any change in ExamWorks' expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

ExamWorks will host a conference call to discuss the results and other matters at 5:00 p.m. Eastern Time. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (888) 455-1227 in the U.S. or (773) 799-3336 internationally with access code 1941106. A live webcast of the call is also accessible through the Investor Relations section of the company’s web site at http://investorrelations.examworks.com/.

Following the conclusion of the call, a replay of the webcast will be available at the Company`s web site within two hours. Alternatively, a telephonic replay of the call will be available at 7:00 p.m. Eastern Time, and can be accessed until August 5^th, 2014 at midnight Eastern Time, by calling (888) 293-8936 in the U.S. or (402) 998-0528 internationally, with access code 562014.

CONTACT:

ExamWorks Group, Inc.

J. Miguel Fernandez de Castro

404-952-2400

Senior Executive Vice President and Chief Financial Officer

investorrelations@examworks.com

SOURCE: ExamWorks Group, Inc.  

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

(In thousands, except share and per share amounts)

(Unaudited)

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

(In thousands, except share and per share amounts)

(Unaudited)

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Reconciliation to Adjusted EBITDA

(In thousands)

(Unaudited)

(1) Share-based compensation expense of $492,000 and $1.2 million is included in costs of revenues for the three and six months ended June 30, 2014, respectively, and the remainder is included in SGA expenses. Share-based compensation expense of $719,000 and $1.4 million is included in costs of revenues for the three and six months ended June 30, 2013, respectively, and the remainder is included in SGA expenses.

(2) Other expenses consist principally of integration related expenses, such as facility termination, severance and relocation costs, associated with our acquisition strategy.